Exports In 2020, China exported $162M in Blood, toxins, cultures, medical use, nes, making it the 11th largest exporter of Blood, toxins, cultures, medical use, nes in the world. At the same year, Blood, toxins, cultures, medical use, nes was the 1640th most exported product in China. The main destination of Blood, toxins, cultures, medical use, nes exports from China are: United States ($50.4M), Ecuador ($15.2M), Brazil ($10.4M), Turkey ($8.32M), and United Kingdom ($8.16M).
The fastest growing export markets for Blood, toxins, cultures, medical use, nes of China between 2019 and 2020 were United States ($32.9M), Ecuador ($13.3M), and Brazil ($5.93M).
Imports In 2020, China imported $571M in Blood, toxins, cultures, medical use, nes, becoming the 3rd largest importer of Blood, toxins, cultures, medical use, nes in the world. At the same year, Blood, toxins, cultures, medical use, nes was the 355th most imported product in China. China imports Blood, toxins, cultures, medical use, nes primarily from: Ireland ($163M), South Korea ($113M), United States ($69.1M), Denmark ($68.3M), and Germany ($34.4M).
The fastest growing import markets in Blood, toxins, cultures, medical use, nes for China between 2019 and 2020 were Germany ($24.6M), Ireland ($20.2M), and Netherlands ($14.2M).
Tariffs In 2018, the average tariff for China in Blood, toxins, cultures, medical use, nes was 2.33%. The countries with the highest import tariffs for Blood, toxins, cultures, medical use, nes were Burkina Faso (Most Favoured Nation duty rate treatement, 3%), Botswana (Most Favoured Nation duty rate treatement, 3%), Cote d'Ivoire (Most Favoured Nation duty rate treatement, 3%), Cameroon (Most Favoured Nation duty rate treatement, 3%), and Democratic Republic of the Congo (Most Favoured Nation duty rate treatement, 3%).